Accessibility/Mobile Features
Skip Navigation
Skip to Content
Editorial News
Business
Classified Sites

The Canadian Press - ONLINE EDITION

Initial public offerings scheduled to debut next week

NEW YORK, N.Y. - The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.

Week of June 16:

Ardelyx Inc. - Fremont, Calif., 3.6 million shares, priced $13 to $15, managed by Citigroup and Leerink Partners. Proposed Nasdaq symbol ARDX. Business: Biotech developing small molecule treatments for kidney and gastrointestinal diseases.

Century Communities Inc. - Greenwood Village, Colo., 4.5 million shares, priced $23 to $26, managed by FBR Capital Markets, J.P. Morgan, and Deutsche Bank. Proposed NYSE symbol CCS. Business: Single-family homebuilder primarily in Colorado, as well as Texas and Nevada.

Eclipse Resources Corp. - State College, Pa., 30.3 million shares, priced $27 to $30, managed by Citigroup, Goldman Sachs, and Morgan Stanley. Proposed NYSE symbol ECR. Business: Oil and natural gas E&P operating in the Appalachian Basin.

Foresight Energy LP - St. Louis, Mo., 17.5 million shares, priced $19 to $21, managed by Barclays, Citigroup, and Morgan Stanley. Proposed NYSE symbol FELP. Business: Spinoff of Foresight Reserves with 3 billion tons of coal reserves in the Illinois basin.

Kite Pharma Inc. - Santa Monica, Calif., 6 million shares, priced $12 to $14, managed by Jefferies, Credit Suisse, and Cowen & Co. Proposed Nasdaq symbol KITE. Business: Clinical stage biotech developing an immunotherapy cancer treatment.

Markit Ltd. - London, U.K., 45.7 million shares, priced 23 to $25, managed by BofA Merrill Lynch, Barclays, and Citigroup. Proposed Nasdaq symbol MRKT. Business: Largest provider of bond information and derivatives trade processing.

Microlin Bio Inc. - New York, 2.7 million shares, priced $10 to $12, managed by Brean Capital and Summer Street Research. Proposed Nasdaq symbol MCLB. Business: Development stage diagnostic and therapeutics company focusing on microRNA and its role in oncology. Issue was previously postponed.

Parnell Pharmaceuticals Holdings Ltd. - Alexandria, Australia, 3.6 million ordinary shares, priced $17 to $19, managed by Jefferies and Piper Jaffray. Proposed Nasdaq symbol PARN. Business: Provides drugs and health software for production and companion animals.

Syndax Pharmaceuticals Inc. - Waltham, Mass., 4.3 million shares, priced $13 to $15, managed by Deutsche Bank and Jefferies. Proposed Nasdaq symbol SNDX. Business: Late-stage biotech developing a novel therapy for treatment-resistant breast cancer.

Viper Energy Partners LP - Midland, Texas, 5 million common units, priced $19 to $21, managed by Barclays, Credit Suisse, and Wells Fargo. Proposed Nasdaq symbol VNOM. Business: Oil and gas E&P in the Permian Basin spun out of Diamondback Energy.

Zafgen Inc. - Cambridge, Mass., 5 million shares, priced $14 to $16, managed by Leerink Partners and Cowen & Co. Proposed Nasdaq symbol ZFGN. Business: Clinical-stage biotech developing treatments for severe obesity and hunger-related disorders.

ZS Pharma Inc. - Coppell, Texas, 5 million shares, priced $15 to $17, managed by J.P. Morgan and Credit Suisse. Proposed Nasdaq symbol ZSPH. Business: Late-stage biotech developing a treatment for excess potassium (hyperkalemia).

  • Rate this Rate This Star Icon
  • This article has not yet been rated.
  • We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high. If you thought it was well written, do the same. If it doesn’t meet your standards, mark it accordingly.

    You can also register and/or login to the site and join the conversation by leaving a comment.

    Rate it yourself by rolling over the stars and clicking when you reach your desired rating. We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high.

Sort by: Newest to Oldest | Oldest to Newest | Most Popular 0 Commentscomment icon

You can comment on most stories on brandonsun.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.

There are no comments at the moment. Be the first to post a comment below.

Post Your Commentcomment icon

Comment
  • You have characters left

The Brandon Sun does not necessarily endorse any of the views posted. Comments are moderated before publication. By submitting your comment, you agree to our Terms and Conditions. New to commenting? Check out our Frequently Asked Questions.

letters

Make text: Larger | Smaller

Brandon Sun Business Directory
Sudden Surge: Flood of 2014
Opportunity Magazine — The Bakken
Why Not Minot?
Welcome to Winnipeg

Social Media

Canadian Mortgage Rates